|
Fredun Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
475.40 Cr.
|
P/BV
|
3.63
|
Book Value (Rs.)
|
277.17
|
|
52 Week High/Low (Rs.)
|
1020/635
|
FV/ML
|
10/1
|
P/E(X)
|
22.85
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
44.07
|
Div Yield (%)
|
0.07
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 44.83 | 33.66 | 24.13 | 11.28 | 5.05 |
| Diluted EPS (Rs.) | 44.83 | 33.32 | 22.93 | 11.28 | 5.05 |
| Cash EPS (Rs.) | 53.49 | 41.32 | 30.04 | 19.16 | 10.07 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 299.47 | 258.49 | 212.64 | 153.54 | 107.96 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 299.47 | 258.49 | 212.64 | 153.54 | 107.96 |
| Dividend / Share (Rs.) | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 |
| Revenue From Operations / Share (Rs.) | 956.66 | 740.88 | 606.04 | 506.38 | 335.60 |
| PBDIT / Share (Rs.) | 116.69 | 82.78 | 65.31 | 34.80 | 26.41 |
| PBIT / Share (Rs.) | 107.27 | 74.70 | 59.11 | 29.93 | 21.39 |
| PBT / Share (Rs.) | 59.87 | 45.65 | 38.63 | 19.40 | 8.04 |
| Net Profit / Share (Rs.) | 44.07 | 33.25 | 23.84 | 14.29 | 5.05 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 12.19 | 11.17 | 10.77 | 6.87 | 7.86 |
| PBIT Margin (%) | 11.21 | 10.08 | 9.75 | 5.91 | 6.37 |
| PBT Margin (%) | 6.25 | 6.16 | 6.37 | 3.83 | 2.39 |
| Net Profit Margin (%) | 4.60 | 4.48 | 3.93 | 2.82 | 1.50 |
| Return on Networth / Equity (%) | 14.71 | 12.86 | 11.21 | 9.30 | 4.67 |
| Return on Capital Employeed (%) | 31.78 | 24.93 | 17.72 | 11.71 | 11.35 |
| Return On Assets (%) | 4.27 | 5.07 | 4.20 | 3.38 | 1.24 |
| Long Term Debt / Equity (X) | 0.06 | 0.10 | 0.50 | 0.61 | 0.67 |
| Total Debt / Equity (X) | 1.18 | 0.86 | 0.89 | 0.77 | 0.92 |
| Asset Turnover Ratio (%) | 1.14 | 1.23 | 1.24 | 1.29 | 0.90 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.31 | 1.54 | 2.04 | 2.07 | 1.50 |
| Quick Ratio (X) | 0.57 | 0.49 | 0.62 | 1.44 | 0.72 |
| Inventory Turnover Ratio (X) | 1.56 | 1.75 | 2.51 | 3.11 | 1.71 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 2.09 | 2.88 | 4.89 | 13.30 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 1.68 | 2.28 | 3.65 | 6.67 |
| Earning Retention Ratio (%) | 0.00 | 97.91 | 97.12 | 95.11 | 86.70 |
| Cash Earning Retention Ratio (%) | 0.00 | 98.32 | 97.72 | 96.35 | 93.33 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 2.46 | 2.85 | 3.19 | 3.30 | 2.53 |
| Interest Coverage Ratio (Post Tax) (%) | 1.93 | 2.14 | 2.16 | 2.36 | 1.76 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 477.26 | 441.23 | 435.36 | 456.41 | 223.45 |
| EV / Net Operating Revenue (X) | 1.06 | 1.27 | 1.59 | 2.03 | 1.67 |
| EV / EBITDA (X) | 8.66 | 11.34 | 14.71 | 29.59 | 21.21 |
| MarketCap / Net Operating Revenue (X) | 0.69 | 0.96 | 1.28 | 1.81 | 1.38 |
| Retention Ratios (%) | 0.00 | 97.90 | 97.11 | 95.10 | 86.69 |
| Price / BV (X) | 2.23 | 2.77 | 3.66 | 5.96 | 4.29 |
| Price / Net Operating Revenue (X) | 0.69 | 0.96 | 1.28 | 1.81 | 1.38 |
| EarningsYield | 0.06 | 0.04 | 0.03 | 0.01 | 0.01 |
